Home/Pipeline/Glioblastoma Moonshot

Glioblastoma Moonshot

Glioblastoma

ResearchOpen Project

Key Facts

Indication

Glioblastoma

Phase

Research

Status

Open Project

Company

Owkin

About Owkin

Founded in 2016 by an oncologist and a machine learning pioneer, Owkin is building an agentic AI infrastructure for biology, aiming to automate R&D and connect research directly to patient care. Its core platform, K Pro, is an AI agent designed to generate and validate therapeutic hypotheses using real-world patient data. The company is well-funded, has commercialized CE-marked diagnostics, and collaborates with a vast network of academic and pharmaceutical partners to advance precision medicine.

View full company profile

Therapeutic Areas

Oncology Glioblastoma Colorectal Cancer Breast Cancer

Other Glioblastoma Drugs

Drug	Company	Phase	Status
Tumor Treating Fields (TTFields)	Zai Lab	Commercial	Commercial in China
Berubicin	CNS Pharmaceuticals	Phase 2/3	Legacy Program - Exploring Out-licensing